Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Nanoparticle immunotherapy

Combo combat

Nature Materials volume 11, pages 831–832 (2012)Cite this article

Subjects

Nanoparticle-enabled, sustained delivery of soluble hydrophilic cytokines and hydrophobic inhibitors engages the innate and adaptive immune systems to fight cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The synthesis and biodegradation of nanolipogels.
Figure 2: The immunosuppressive tumour microenvironment and mechanism of action of nanolipogels.

References

  1. Halford, B. Chem. Eng. News 90, 10–15 (2012).

    Google Scholar 

  2. Flavell, R. A., Sanjabi, S., Wrzesinski, S. H. & Licona-Limón, P. Nature Rev. Immunol. 10, 554–567 (2010).

    Article  CAS  Google Scholar 

  3. Smyth, M. J. et al. J. Immunol. 176, 1582–1587 (2006).

    Article  CAS  Google Scholar 

  4. Wrzesinski, S. H., Wan, Y. Y., Flavell, R. A. Clin. Cancer Res. 13, 5262–5270 (2007).

    Article  CAS  Google Scholar 

  5. Acquavella, N. et al. J. Immunother. 31, 569–576 (2008).

    Article  CAS  Google Scholar 

  6. Park, J. et al. Nature Mater. 11, 895–905 (2012).

    Article  CAS  Google Scholar 

  7. Shi, J., Votruba, A. R., Farokhzad, O. C. & Langer, R. Nano Lett. 10, 3223–3230 (2010).

    Article  CAS  Google Scholar 

  8. Torchilin, V. P. Nature Rev. Drug Discov. 4, 145–160 (2005).

    Article  CAS  Google Scholar 

  9. Kano, M. R. et al. Proc. Natl Acad. Sci. USA 104, 3460–3465 (2007).

    Article  CAS  Google Scholar 

  10. Meng, H. et al. ACS Nano 4, 4539–4550 (2010).

    Article  CAS  Google Scholar 

  11. Ashley, C. E. et al. Nature Mater. 10, 389–397 (2011).

    Article  CAS  Google Scholar 

  12. Meng, H. et al. J. Am. Chem. Soc. 132, 12690–12697 (2010).

    Article  CAS  Google Scholar 

  13. Carvalho, L. V. et al. Vaccine 28, 7829–7836 (2010).

    Article  CAS  Google Scholar 

  14. Von Maltzahn, G. et al. Nature Mater. 10, 545–552 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. C. Jeffrey Brinker is in the Department of Chemical and Nuclear Engineering and the Department of Molecular Genetics and Microbiology, University of New Mexico, 1001 University Boulevard SE, Albuquerque, New Mexico 87131, USA,

    C. Jeffrey Brinker

  2. Sandia National Laboratories, Albuquerque, New Mexico 87185, USA,

    C. Jeffrey Brinker

  3. the UNM Cancer Center, Albuquerque, New Mexico 87131, USA,

    C. Jeffrey Brinker

Authors
  1. C. Jeffrey Brinker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Jeffrey Brinker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brinker, C. Combo combat. Nature Mater 11, 831–832 (2012). https://doi.org/10.1038/nmat3434

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nmat3434

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research